Journals / Koşuyolu Heart Journal / 2019 / Cilt: 22 - Sayı: 1

Resting Heart Rate is Not Associated with Oxidative Stress in Healthy Adults

Sağlıklı Erişkinlerde İstirahat Kalp Hızı Oksidatif Stresle İlişkili Değildir

Pages
20–24
Publication Date
2019-04-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: RHR was not associated with TOS, TAC, OSI, and CP levels in our study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Although resting heart rate (RHR) and oxidative stress are risk factors for cardiovascular morbidity and mortality, the association between them has not been fully understood.
📊
Key Findings & Data:Patients and Methods: The study consisted of 56 healthy volunteers (33 males; mean age: 44.1 ± 9.0 years).
💡
Conclusion & Impact:Conclusion: RHR was not associated with TOS, TAC, OSI, and CP levels in our study.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İstirahat kalp hızı · oksidatif stres · total oksidan kapasitesi

Abstract

Introduction: Although resting heart rate (RHR) and oxidative stress are risk factors for cardiovascular morbidity and mortality, the association between them has not been fully understood. The aim of the present study was to investigate the relationship between RHR and oxidative/antioxidative stress markers. Patients and Methods: The study consisted of 56 healthy volunteers (33 males; mean age: 44.1 ± 9.0 years). Subjects were divided into two groups according to heart rate quartiles: lower two quartiles as group 1 (n= 29) and upper two quartiles as group 2 (n= 27). We measured total oxidant status (TOS), total antioxidant capacity (TAC), oxidative stress index (OSI), and ceruloplasmin (CP) levels of subjects. Results: There was no any significant difference in baseline clinical characteristics and laboratory measurements between the groups (p> 0.05 for all variables). Mean RHRs were 71.3 ± 4.6 in group 1 and 82.4 ± 4.1 in group 2. The TAC, TOS, OSI, and CP levels were similar between the two groups (p> 0.05 for all variables). We did not detect any significant association between RHR and oxidative/antioxidative parameters. Conclusion: RHR was not associated with TOS, TAC, OSI, and CP levels in our study.

Özet

Giriş: Her ne kadar istirahat kalp hızı (İKH) ve oksidatif stres, kardiyovasküler morbidite ve mortalite için risk faktörleri olsa da bunlar arasındaki ilişki tam olarak anlaşılamamıştır. Bu çalışmamızda, İKH ile oksidatif/ antioksidatif stres belirteçleri arasındaki ilişkiyi araştırmayı amaçladık. Hastalar ve Yöntem: Çalışma 56 sağlıklı gönüllüden (33 erkek; ortalama yaş: 44.1 ± 9.0 yıl) oluşmaktaydı. Gönüllüler kalp hızı çeyrekliklerine göre iki gruba bölündüler: alt iki çeyreklik grup 1 (n= 29) ve üst iki çeyreklik grup 2 (n= 27). Hastaların total oksidan kapasitesi (TOK), total antioksidan kapasitesi (TAK), oksidatif stres indeksi (OSİ) ve serum seruloplasmin düzeylerini ölçük. Bulgular: Bazal klinik karakteristikler ve laboratuvar ölçümleri açısında iki grup arasında önemli bir fark yoktu (p> 0.05 tüm değişkenler için). Ortalama İKH grup 1᾽de 71.3 ± 4.6 iken grup 2᾽de 82.4 ± 4.1 idi. TOK, TAK, OSİ ve seruloplazmin düzeyleri her iki grupta benzerdi (p> 0.05 tüm değişkenler için). İKH ve oksidatif/antioksidatif stres parametreleri arasında anlamlı bir ilişki saptayamadık. Sonuç: Çalışmamızda İKH, TOK, TAK, OSİ ve seruloplazmin düzeyleri ile ilişkili bulunmadı.

🔖

Cite This Article

BAYSAL, S. S. (2019). Resting Heart Rate is Not Associated with Oxidative Stress in Healthy Adults. Koşuyolu Heart Journal, Cilt: 22 - Sayı: 1, 20–24. https://ajindex.com/articles/63862

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tverdal A, Hjellvik V, Selmer R. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379 843 men and women aged 40-45 years. Eur Heart J 2008;29:2772-81
  2. Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000;21:116-24
  3. Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol 2012;19:102-8
  4. Johansen CD, Olsen RH, Pedersen LR, Kumarathurai P, Mouridsen MR, Binici Z, et al. Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease. Eur Heart J 2013; 34:1732-9
  5. Lee DH, de Rezende LFM, Hu FB, Jeon JY, Giovannucci EL. Resting heart rate and risk of type 2 diabetes: a prospective cohort study and meta-analysis. Diabetes Metab Res Rev 2019:e3095
  6. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 2008;126:302-12
  7. Beere PA, Glagov S, Zarins CK. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement, and the sparing effect of lowered heart rate. Arterioscler Thromb 1992;12:1245-53
  8. Opdahl A, Venkatesh BA, Fernandes VR, Wu CO, Nasir K, Choi EY, et al. Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2014;63:1182-9
  9. Simula S, Vanninen E, Lehto S, Hedman A, Pajunen P, Syvänne M, et al. Heart rate variability associates with asymptomatic coronary atherosclerosis. Clin Auton Res 2014;24:31-7
  10. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008;372:817-21
  11. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-3
  12. Baumhäkel M, Custodis F, Schlimmer N, Laufs U, Böhm M. Heart rate reduction with ivabradine improves e